Shandong Xinhua Pharmaceutical Company Limited (FRA:XIN)

FRA:XIN Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,130	1,154	1,378	2,129	772	574
Market Cap Growth	-4.36%	-16.23%	-35.28%	175.78%	34.40%	15.79%
Enterprise Value	1,194	1,254	1,471	2,125	922	681
Last Close Price	0.73	0.66	0.58	0.81	0.45	0.28
PE Ratio	24.70	18.56	21.75	38.17	16.00	14.12
PS Ratio	1.11	1.03	1.33	2.09	0.85	0.76
PB Ratio	1.75	1.67	2.26	3.61	1.53	1.35
P/TBV Ratio	2.06	1.97	2.66	4.30	1.86	1.65
P/FCF Ratio	35.10	56.20	-	30.56	563.90	32.76
P/OCF Ratio	21.68	23.73	40.71	20.70	21.52	10.92
EV/Sales Ratio	1.17	1.12	1.42	2.09	1.01	0.91
EV/EBITDA Ratio	9.92	9.03	11.24	16.45	7.93	6.45
EV/EBIT Ratio	22.58	18.56	22.52	33.62	16.50	11.86
EV/FCF Ratio	37.08	61.05	-	30.51	673.39	38.85
Debt / Equity Ratio	0.28	0.32	0.28	0.32	0.45	0.49
Debt / EBITDA Ratio	1.52	1.58	1.32	1.45	1.95	1.95
Debt / FCF Ratio	5.66	10.74	-	2.70	166.46	11.75
Asset Turnover	0.95	0.98	0.98	0.96	0.91	0.89
Inventory Turnover	5.40	5.01	4.58	4.93	4.48	3.77
Quick Ratio	0.85	0.85	0.76	0.68	0.65	0.59
Current Ratio	1.31	1.33	1.33	1.09	1.10	1.13
Return on Equity (ROE)	7.59%	9.74%	11.09%	10.65%	10.28%	10.68%
Return on Assets (ROA)	3.06%	3.69%	3.87%	3.73%	3.50%	4.24%
Return on Capital (ROIC)	4.01%	4.90%	5.39%	5.28%	4.88%	5.93%
Return on Capital Employed (ROCE)	7.20%	8.20%	8.80%	9.10%	8.40%	9.70%
Earnings Yield	4.05%	5.39%	4.60%	2.62%	6.25%	7.08%
FCF Yield	2.85%	1.78%	-0.55%	3.27%	0.18%	3.05%
Dividend Yield	4.19%	5.48%	5.46%	3.34%	4.57%	6.81%
Payout Ratio	55.78%	48.05%	35.43%	39.66%	42.59%	39.05%
Buyback Yield / Dilution	0.13%	0.54%	-3.20%	-6.93%	0.02%	-0.86%
Total Shareholder Return	4.32%	6.02%	2.26%	-3.58%	4.59%	5.95%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.